LISATA THERAPEUTICS, INC. Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2011 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Lisata Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2011 to Q2 2024.
  • Lisata Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $237K, a 59.4% decline year-over-year.
  • Lisata Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $1.47M, a 46.9% decline year-over-year.
  • Lisata Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $2.04M, a 22.7% decline from 2022.
  • Lisata Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $2.64M, a 31.5% increase from 2021.
  • Lisata Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $2.01M, a 58.5% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $1.47M $237K -$347K -59.4% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $1.82M $454K -$221K -32.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $2.04M $473K +$4K +0.85% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 $2.03M $306K -$734K -70.6% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $2.77M $584K +$217K +59.1% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 $2.55M $675K -$85K -11.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $2.64M $469K +$104K +28.5% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 $2.53M $1.04M +$267K +34.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $2.27M $367K +$97K +35.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $2.17M $760K +$163K +27.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $2.01M $365K +$191K +110% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 $1.81M $773K +$544K +238% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $1.27M $270K -$25K -8.48% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $1.3M $597K +$30K +5.29% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $1.27M $174K -$75K -30.1% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-22
Q3 2020 $1.34M $229K -$25K -9.84% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $1.37M $295K +$50K +20.4% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $1.32M $567K +$20K +3.66% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $1.3M $249K +$78K +45.6% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-25
Q3 2019 $1.22M $254K +$87K +52.1% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $1.13M $245K -$1.72M -87.6% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 $2.85M $547K +$400K +272% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $2.45M $171K +$89K +109% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-05
Q3 2018 $2.36M $167K +$105K +169% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 $2.26M $1.97M -$207K -9.52% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $2.47M $147K -$386K -72.4% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 $2.85M $82K -$295K -78.2% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-14
Q3 2017 $3.15M $62K -$979K -94% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 $4.13M $2.18M +$1.84M +548% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $2.29M $533K -$318K -37.4% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 $2.6M $377K -$104K -21.6% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-22
Q3 2016 $2.71M $1.04M +$604K +138% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 $2.1M $336K -$4.08M -92.4% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-10
Q1 2016 $6.19M $851K -$3.57M -80.7% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 $9.75M $481K -$1.79M -78.8% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-17
Q3 2015 $11.5M $437K -$2.85M -86.7% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-07
Q2 2015 $14.4M $4.42M +$2.66M +151% Apr 1, 2015 Jun 30, 2015 10-Q 2015-08-06
Q1 2015 $11.7M $4.42M +$523K +13.4% Jan 1, 2015 Mar 31, 2015 10-Q 2016-08-09
Q4 2014 $11.2M $2.27M +$871K +62.4% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-15
Q3 2014 $10.3M $3.29M +$1.16M +54.5% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-05
Q2 2014 $9.18M $1.76M +$664K +60.6% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-06
Q1 2014 $8.51M $3.89M +$1.68M +75.5% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-06
Q4 2013 $6.84M $1.4M +$164K +13.3% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-15
Q3 2013 $6.68M $2.13M +$211K +11% Jul 1, 2013 Sep 30, 2013 10-Q 2014-10-30
Q2 2013 $6.46M $1.1M +$9.3K +0.86% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-07
Q1 2013 $6.45M $2.22M -$258K -10.4% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-08
Q4 2012 $6.71M $1.23M Oct 1, 2012 Dec 31, 2012 10-K 2015-03-02
Q3 2012 $1.92M +$408K +27.1% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-07
Q2 2012 $1.09M -$3.66M -77.1% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-08
Q1 2012 $2.48M Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-09
Q3 2011 $1.51M Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-13
Q2 2011 $4.75M Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.